fatty liver/diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Outpatients or inpatients who underwent fibroscan examination at Shanghai Pudong Punan Hospital between 2023.07.20 and 2024.05.20 (Instrument model: Fibroscan HANDY) Fibroscan data should be complete and valid, and the instrument should be operated in accordance with the Fibroscan HANDY operation manual.
Exclusion criteria
Exclusion criteria: 1. patients aged 90 years; 2. No history of liver surgery such as liver transplantation or partial hepatectomy; 3. no serious systemic disease or any other condition that affects the patient's ability or compliance such as pregnancy, heart failure, clinically significant heart valve disease, serious mental illness and active malignant disease; 4. patients who are participating in clinical trials of other drugs that would cause fatty liver; 5. patients with diseases that would affect the accuracy of the fibroscan test, such as patients with severe decompensated cirrhosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Controlled attenuation parameter;Liver stiffness measurement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycosylated Hemoglobin;Glutamic pyruvic transaminase;Glutamic oxaloacetic transaminase;Fasting C-Peptide;Fasting insulin;Triglycerid;Cholesterol;Low density lipoprotein;H density lipoprotein;total bilirubin;albumin;prealbumin;?-glutamyltranspeptidase;alkaline phosphatase;fasting blood-glucose;creatinine;eGFR;blood platelet;international normalized ratio;height;weight;body mass index;blood pressure; | — |
Countries
China
Contacts
Shanghai Jiao Tong University Renji Hospital Punan Branch